Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Intensive Care Medicine
Published in: Intensive Care Medicine 6/2015

01-06-2015 | Correspondence

Use of Type III procollagen measurement as predictor of lung fibroproliferation in ARDS: early measurement for earlier antifibroproliferative therapy?

Authors: Rémi Coudroy, Angéline Jamet, Oscar Peñuelas, Arnaud W. Thille

Published in: Intensive Care Medicine | Issue 6/2015

Login to get access

Excerpt

Dear Editor, …
Literature
1.
Forel JM, Guervilly C, Hraiech S, Voillet F, Thomas G, Somma C, Secq V, Farnarier C, Payan MJ, Donati SY, Perrin G, Trousse D, Dizier S, Chiche L, Baumstarck K, Roch A, Papazian L (2015) Type III procollagen is a reliable marker of ARDS-associated lung fibroproliferation. Intensive Care Med 41:1–11. doi:10.​1007/​s00134-014-3524-0 PubMedCrossRef
2.
Meduri GU, Golden E, Freire AX, Taylor E, Zaman M, Carson SJ, Gibson M, Umberger R (2007) Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial. Chest 131:954–963PubMedCrossRef
3.
Steinberg KP, Hudson LD, Goodman RB, Hough CL, Lanken PN, Hyzy R, Thompson BT, Ancukiewicz M, National Heart L, Blood Institute Acute Respiratory Distress Syndrome Clinical Trials (2006) Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med 354:1671–1684PubMedCrossRef
4.
Guerin C, Bayle F, Leray V, Debord S, Stoian A, Yonis H, Roudaut JB, Bourdin G, Devouassoux-Shisheboran M, Bucher E, Ayzac L, Lantuejoul S, Philipponnet C, Kemeny JL, Souweine B, Richard JC (2015) Open lung biopsy in nonresolving ARDS frequently identifies diffuse alveolar damage regardless of the severity stage and may have implications for patient management. Intensive Care Med 41:222–230. doi:10.​1007/​s00134-014-3583-2 PubMedCrossRef
5.
Thille AW, Esteban A, Fernández-Segoviano P, Rodriguez J-M, Aramburu J-A, Vargas-Errázuriz P, Martín-Pellicer A, Lorente JA, Frutos-Vivar F (2013) Chronology of histological lesions in acute respiratory distress syndrome with diffuse alveolar damage: a prospective cohort study of clinical autopsies. Lancet Respir Med 1:395–401PubMedCrossRef
Metadata
Title
Use of Type III procollagen measurement as predictor of lung fibroproliferation in ARDS: early measurement for earlier antifibroproliferative therapy?
Authors
Rémi Coudroy
Angéline Jamet
Oscar Peñuelas
Arnaud W. Thille
Publication date
01-06-2015
Publisher
Springer Berlin Heidelberg
Published in
Intensive Care Medicine / Issue 6/2015
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-015-3758-5

Other articles of this Issue 6/2015

Intensive Care Medicine 6/2015 Go to the issue

Original

Multinational development and validation of an early prediction model for delirium in ICU patients

Understanding the Disease

Understanding the benefits and harms of oxygen therapy

Letter

Can inferior vena cava saturations be used instead of ScvO2 in children with septic shock?

Correspondence

The effect of hemodynamic monitoring depends entirely on the action that it leads to: response to comments by Cronhjort et al.

Letter

Life-threatening complications of acute pancreatitis

Systematic Review

Mechanical ventilation during extracorporeal life support (ECLS): a systematic review